FDA Approved: PHYRAGO — Original Application (Cycle Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved PHYRAGO (dasatinib) from Cycle Pharmaceuticals Ltd under an original application. Dasatinib is indicated for Philadelphia chromosome-positive l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• PHYRAGO (DASATINIB)

Snippet

ORIG AP for PHYRAGO (DASATINIB)